Boston Scientific Corp. vs. Heartflow, Inc. Common Stock
Boston Scientific Corp. (BSX) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BSX | HTFL | |
|---|---|---|
| Market Cap | $63.93 billion | $4.28 billion |
| Revenue (TTM) | $21.00 billion | $212.07 million |
| Net Income (TTM) | $3.67 billion | $-118,373,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | HTFL | |
|---|---|---|
| P/E Ratio | 17.56 | — |
| Price / Book | 2.54 | 15.28 |
| Price / Sales | 3.04 | 20.16 |
BSX leads on 2 of 2 valuation factors.
Profitability
| BSX | HTFL | |
|---|---|---|
| Net Margin | 17.47% | -55.82% |
| Return on Equity | 14.57% | -42.32% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | HTFL | |
|---|---|---|
| Short Interest | 0.72% | 0.53% |
HTFL leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, HTFL overview, HTFL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
